bigvision

Recently, the tenth “Wu Wenjun Artificial Intelligence Science and Technology Award” was officially announced. The “Wu Wenjun Artificial Intelligence Science and Technology Award” is named after Mr. Wu Wenjun, an outstanding scientist, mathematics master, pioneer of artificial intelligence, pioneer and leader of intelligent science research in China, winner of the first National Supreme Science and Technology Award, academician of the Chinese Academy of Sciences, researcher of the Institute of Mathematics and System Sciences of the Chinese Academy of Sciences, and

On November 20, 2020, the 25th National Ophthalmology Congress of the Chinese Medical Association met with us at the Xiamen International Convention and Exhibition Center as scheduled. The main theme of this meeting was “Chasing Light and Dreams, Never Forgetting the Beginning, Combating Epidemics”. Since its establishment in 2015, Big Vision has never missed this annual ophthalmology event, which also represents Big Vision’s insistence and persistence on applying advanced artificial intelligence technology to empower ophthalmology treatment. In this year’s annual

On September 8, Hu Yan, director of the Department of Science and Technology of the State Ministry of Industry and Information Technology, Xu Peng, director of the High Technology Division of the Department of Science and Technology, Hu Juwen, vice mayor of Ganzhou City, Bu Zhiyi, leader of Zhanggong District, and other leaders visited Jiangxi Big Vision to understand the products and development of the enterprise, and care about the practical problems encountered in the development of the enterprise and

Against the backdrop of the ongoing implementation of China’s Smart Manufacturing 2025 program, China’s economy is growing rapidly and technology is advancing by the day. In the field of big data artificial intelligence, the number of Chinese startups and potential unicorns is similar to that of the United States, which is very bright. Big Vision, as a company that has been cultivating in the field of artificial intelligence for more than ten years and has made significant breakthroughs in developing

On December 20, 2019 Future Healthcare 100 Conference hosted by Artery.com was held in Beijing Jiuhua Villa International Conference Center. The 2019 Future Healthcare 100 Conference is an annual event under Artery.com, which aims to gather the core strengths of the industry and promote the process of change in the innovative healthcare industry. The theme of the conference is “The New Increment of Life”, which showcases the innovation ecology of China’s healthcare sector around the industry, technology environment and demand

In recent years, artificial intelligence has shown excellent technical strength and development prospects in the field of healthcare, and a large number of products have entered the market transformation stage both at home and abroad. In order to meet the development needs of the medical device industry, in March 2019, the State Drug Administration issued the “Artificial Intelligence Medical Device Standardization Technical Focal Point Unit Formation Program”. Artificial intelligence medical device standardization technology focal point unit is mainly responsible for

Instead of being cold, the Xintiandi Home Community Service Center was unusually warm in winter. Big Vision came here with a new generation of fully automated artificial intelligence OCT BV1000 to provide intimate fundus screening services to the elderly in the community. This is the third consecutive year that Chen Xinjian, a member of the Jiangsu Provincial Committee of the Chinese People’s Political Consultative Conference and chairman of Suzhou Big Vision. The BV 1000 used in this public health screening is

Winter is slowly and gracefully approaching as we meet on the banks of the Huangpu River for the academic event in the field of fundus disease – Retina China 2020 Forum and International Retina Symposium (Retina China 2020). For the first time, Big Vision presented the new generation of fully automated artificial intelligence OCT BV1000. The Big Vision BV 1000 is a fully automatic artificial intelligence OCT with fully independent intellectual property rights of hardware and software. Unlike existing OCTs, it

It’s time for the annual national ophthalmology conference. At noon on September 6, 2019, Big Vision held a satellite session on “Clinical Application of Ophthalmic Bi-Modal Artificial Intelligence System”, where three top ophthalmologists spoke about their experiences with the Big Vision Bi-Modal Ophthalmic Imaging Artificial Intelligence System The story of MIAS. The AI can be used for clinical verification. Professor Qu Jia, Director of Wenzhou Medical University Optometry Center, presented the results of the clinical validation of the MIAS in cooperation

On August 14, Tao Guanhong, deputy director of Suzhou High-tech Zone Management Committee, Gu Caiya, director of District Science and Technology Innovation Bureau, Shen Peiying, deputy director, Li Wei, director of Venture Park and other leaders came to visit and investigate Big Vision to understand the product technology and development of the company, and care about the practical problems encountered in the development of the company and the support needed to be given. Company chairman Chen Xinjian, deputy general manager